# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-002560
Filing Date
2022-03-01
Accepted
2022-03-01 16:36:40
Documents
129
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | rptx-20211231.htm iXBRL | 10-K | 4621531
2 | EX-10.11 | rptx-ex10_11.htm | EX-10.11 | 149151
3 | EX-10.27 | rptx-ex10_27.htm | EX-10.27 | 52351
4 | EX-10.28 | rptx-ex10_28.htm | EX-10.28 | 41729
5 | EX-23.1 | rptx-ex23_1.htm | EX-23.1 | 4743
6 | EX-31.1 | rptx-ex31_1.htm | EX-31.1 | 20123
7 | EX-31.2 | rptx-ex31_2.htm | EX-31.2 | 20174
8 | EX-32.1 | rptx-ex32_1.htm | EX-32.1 | 22065
9 | GRAPHIC | img115829461_0.jpg | GRAPHIC | 16983
10 | GRAPHIC | img191397607_0.jpg | GRAPHIC | 391493
11 | GRAPHIC | img191397607_1.jpg | GRAPHIC | 137142
12 | GRAPHIC | img191397607_2.jpg | GRAPHIC | 121086
13 | GRAPHIC | img191397607_3.jpg | GRAPHIC | 104876
14 | GRAPHIC | img191397607_4.jpg | GRAPHIC | 90964
15 | GRAPHIC | img191397607_5.jpg | GRAPHIC | 119371
16 | GRAPHIC | img191397607_6.jpg | GRAPHIC | 239237
17 | GRAPHIC | img191397607_7.jpg | GRAPHIC | 23476
18 | GRAPHIC | img191397607_8.jpg | GRAPHIC | 65241
19 | GRAPHIC | img191397607_9.jpg | GRAPHIC | 62234
20 | GRAPHIC | img191397607_10.jpg | GRAPHIC | 176473
21 | GRAPHIC | img191397607_11.jpg | GRAPHIC | 92397
22 | GRAPHIC | img191397607_12.jpg | GRAPHIC | 82749
23 | GRAPHIC | img191397607_13.jpg | GRAPHIC | 407799
24 | GRAPHIC | img191397607_14.jpg | GRAPHIC | 8100
25 | GRAPHIC | img191397607_15.jpg | GRAPHIC | 47709
26 | GRAPHIC | img191397607_16.jpg | GRAPHIC | 143207
27 | GRAPHIC | img191397607_17.jpg | GRAPHIC | 173688
28 | GRAPHIC | img191397607_18.jpg | GRAPHIC | 190908
29 | GRAPHIC | img191397607_19.jpg | GRAPHIC | 214886
30 | GRAPHIC | img191397607_20.jpg | GRAPHIC | 182555
31 | GRAPHIC | img191397607_21.jpg | GRAPHIC | 1403062
| Complete submission text file | 0000950170-22-002560.txt |  | 25412383

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
32 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | rptx-20211231_lab.xml | EX-101.LAB | 635351
33 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | rptx-20211231_cal.xml | EX-101.CAL | 73283
34 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | rptx-20211231_pre.xml | EX-101.PRE | 511894
35 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | rptx-20211231_def.xml | EX-101.DEF | 292278
36 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | rptx-20211231.xsd | EX-101.SCH | 84758
123 | EXTRACTED XBRL INSTANCE DOCUMENT | rptx-20211231_htm.xml | XML | 2680707

Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39335 | Film No.: 22698787
SIC: 2834 Pharmaceutical Preparations